{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:32:17Z","timestamp":1793525537929,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Innovation Fund Project of Chengdu University of TCM and Affiliated Hospitals","award":["LH202402056"],"award-info":[{"award-number":["LH202402056"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92049120"],"award-info":[{"award-number":["92049120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00637-w","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:14:21Z","timestamp":1752671661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Integrated machine learning and deep learning-based virtual screening framework identifies novel natural GSK-3\u03b2 inhibitors for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Ya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Rong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ling","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"637_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113208","volume":"152","author":"M-R Ding","year":"2022","unstructured":"Ding M-R, Qu Y-J, Hu B, An H-M (2022) Signal pathways in the treatment of Alzheimer\u2019s disease with traditional Chinese medicine. Biomed Pharmacother 152:113208. https:\/\/doi.org\/10.1016\/j.biopha.2022.113208","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"637_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better MA (2023) Alzheimer\u2019s disease facts and figures. Alzheimer Dementia 19(4):1598\u20131695. https:\/\/doi.org\/10.1002\/alz.13016","journal-title":"Alzheimer Dementia"},{"issue":"1","key":"637_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1474-4422(19)30290-x","volume":"19","author":"L Jia","year":"2020","unstructured":"Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, Tang Y, Qin Q, Wang F, Qiao Y, Shi S, Wang YJ, Du Y, Zhang J, Zhang J, Luo B, Qu Q, Zhou C, Gauthier S, Jia J (2020) Dementia in China: epidemiology, clinical management, and research advances. The Lancet Neurology 19(1):81\u201392. https:\/\/doi.org\/10.1016\/s1474-4422(19)30290-x","journal-title":"The Lancet Neurology"},{"issue":"7715","key":"637_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/d41586-018-05717-6","volume":"559","author":"R Hodson","year":"2018","unstructured":"Hodson R (2018) Alzheimer\u2019s disease. Nature 559(7715):S1. https:\/\/doi.org\/10.1038\/d41586-018-05717-6","journal-title":"Nature"},{"key":"637_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102229","volume":"95","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, Karan A, Sharma R, Sharma NS, Sundar V, Jayaraj R, Mukherjee S, DeCoster MA (2024) Evolving therapeutic interventions for the management and treatment of Alzheimer\u2019s disease. Ageing Res Rev 95:102229. https:\/\/doi.org\/10.1016\/j.arr.2024.102229","journal-title":"Ageing Res Rev"},{"issue":"1","key":"637_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) New approaches to symptomatic treatments for Alzheimer\u2019s disease. Mol Neurodegener 16(1):2. https:\/\/doi.org\/10.1186\/s13024-021-00424-9","journal-title":"Mol Neurodegener"},{"issue":"2","key":"637_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14283\/jpad.2017.12","volume":"4","author":"J Cummings","year":"2017","unstructured":"Cummings J, Fox N (2017) Defining disease modifying therapy for Alzheimer\u2019s disease. J Prevent Alzheimer Dis 4(2):109\u2013115. https:\/\/doi.org\/10.14283\/jpad.2017.12","journal-title":"J Prevent Alzheimer Dis"},{"key":"637_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102595","volume":"103","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen J, Li Y, Jiao B, Luo S (2025) Disease-modifying therapies for Alzheimer\u2019s disease: clinical trial progress and opportunity. Ageing Res Rev 103:102595. https:\/\/doi.org\/10.1016\/j.arr.2024.102595","journal-title":"Ageing Res Rev"},{"key":"637_CR9","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.2147\/ijn.S444115","volume":"18","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Liu Y, Ruan S, Hu Y (2023) Current anti-amyloid-\u03b2 therapy for Alzheimer\u2019s disease treatment: from clinical research to nanomedicine. Int J Nanomed 18:7825\u20137845. https:\/\/doi.org\/10.2147\/ijn.S444115","journal-title":"Int J Nanomed"},{"issue":"1","key":"637_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.proghi.2016.01.001","volume":"51","author":"AS Hung","year":"2016","unstructured":"Hung AS, Liang Y, Chow TC, Tang HC, Wu SL, Wai MS, Yew DT (2016) Mutated tau, amyloid and neuroinflammation in Alzheimer disease-a brief review. Prog Histochem Cytochem 51(1):1\u20138. https:\/\/doi.org\/10.1016\/j.proghi.2016.01.001","journal-title":"Prog Histochem Cytochem"},{"issue":"5","key":"637_CR11","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res 1867(5):118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"637_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/jci64516","volume":"123","author":"PT Ly","year":"2013","unstructured":"Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, Zhang M, Yang Y, Cai F, Woodgett J, Song W (2013) Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Investig 123(1):224\u2013235. https:\/\/doi.org\/10.1172\/jci64516","journal-title":"J Clin Investig"},{"issue":"1","key":"637_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/s1461145711000149","volume":"15","author":"C-H Chen","year":"2012","unstructured":"Chen C-H, Zhou W, Liu S, Deng Y, Cai F, Tone M, Tone Y, Tong Y, Song W (2012) Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 15(1):77\u201390. https:\/\/doi.org\/10.1017\/s1461145711000149","journal-title":"Int J Neuropsychopharmacol"},{"key":"637_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.intimp.2019.02.053","volume":"70","author":"C Sathiya Priya","year":"2019","unstructured":"Sathiya Priya C, Vidhya R, Kalpana K, Anuradha CV (2019) Indirubin-3\u2032-monoxime prevents aberrant activation of GSK-3\u03b2\/NF-\u03baB and alleviates high fat-high fructose induced A\u03b2-aggregation, gliosis and apoptosis in mice brain. Int Immunopharmacol 70:396\u2013407. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.053","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"637_CR15","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s12035-023-03839-1","volume":"61","author":"RC Sequeira","year":"2024","unstructured":"Sequeira RC, Godad A (2024) Understanding glycogen synthase kinase-3: a novel avenue for Alzheimer\u2019s disease. Mol Neurobiol 61(7):4203\u20134221. https:\/\/doi.org\/10.1007\/s12035-023-03839-1","journal-title":"Mol Neurobiol"},{"issue":"6","key":"637_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","volume":"99","author":"T Engel","year":"2006","unstructured":"Engel T, Go\u00f1i-Oliver P, Lucas JJ, Avila J, Hern\u00e1ndez F (2006) Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J Neurochem 99(6):1445\u20131455. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04139.x","journal-title":"J Neurochem"},{"key":"637_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040721","author":"CL Sayas","year":"2021","unstructured":"Sayas CL, \u00c1vila J (2021) GSK-3 and Tau: a key duet in Alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells10040721","journal-title":"Cells"},{"key":"637_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exger.2016.09.003","volume":"84","author":"ZX Zhang","year":"2016","unstructured":"Zhang ZX, Zhao RP, Wang DS, Wang AN (2016) Fuzhisan ameliorates A\u03b2 production and tau phosphorylation in hippocampal of 11month old APP\/PS1 transgenic mice: a western blot study. Exp Gerontol 84:88\u201395. https:\/\/doi.org\/10.1016\/j.exger.2016.09.003","journal-title":"Exp Gerontol"},{"issue":"7","key":"637_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14818","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, Zhou Y (2024) GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther 30(7):e14818. https:\/\/doi.org\/10.1111\/cns.14818","journal-title":"CNS Neurosci Ther"},{"key":"637_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6931","author":"F Zhang","year":"2020","unstructured":"Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, Tao J, Sha B, Liu Z, Saito T, Saido T, Keene CD, Jiao K, Roberson ED, Xu H, Wang Q (2020) \u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay6931","journal-title":"Sci Transl Med"},{"key":"637_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lfs.2016.06.020","volume":"158","author":"A Noel","year":"2016","unstructured":"Noel A, Barrier L, Ingrand S (2016) The Tyr216 phosphorylated form of GSK3\u03b2 contributes to tau phosphorylation at PHF-1 epitope in response to A\u03b2 in the nucleus of SH-SY5Y cells. Life Sci 158:14\u201321. https:\/\/doi.org\/10.1016\/j.lfs.2016.06.020","journal-title":"Life Sci"},{"issue":"12","key":"637_CR22","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/hmg\/dds100","volume":"21","author":"H Park","year":"2012","unstructured":"Park H, Kam TI, Kim Y, Choi H, Gwon Y, Kim C, Koh JY, Jung YK (2012) Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2. Hum Mol Genet 21(12):2725\u20132737. https:\/\/doi.org\/10.1093\/hmg\/dds100","journal-title":"Hum Mol Genet"},{"issue":"52","key":"637_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2414176121","volume":"121","author":"P Chakraborty","year":"2024","unstructured":"Chakraborty P, Ib\u00e1\u00f1ez de Opakua A, Purslow JA, Fromm SA, Chatterjee D, Zachrdla M, Zhuang S, Puri S, Wolozin B, Zweckstetter M (2024) GSK3\u03b2 phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments. Proc Natl Acad Sci USA 121(52):e2414176121. https:\/\/doi.org\/10.1073\/pnas.2414176121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"637_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0891-0618(99)00012-5","volume":"16","author":"K Leroy","year":"1999","unstructured":"Leroy K, Brion J-P (1999) Developmental expression and localization of glycogen synthase kinase-3\u03b2 in rat brain. J Chem Neuroanat 16(4):279\u2013293. https:\/\/doi.org\/10.1016\/S0891-0618(99)00012-5","journal-title":"J Chem Neuroanat"},{"key":"637_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.016","journal-title":"Pharmacol Ther"},{"key":"637_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnsyn.2017.00002","volume":"9","author":"CN Meunier","year":"2017","unstructured":"Meunier CN, Chameau P, Fossier PM (2017) Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players. Front Synaptic Neurosci 9:2. https:\/\/doi.org\/10.3389\/fnsyn.2017.00002","journal-title":"Front Synaptic Neurosci"},{"issue":"6","key":"637_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1471-4159.2011.07532.x","volume":"119","author":"T Onishi","year":"2011","unstructured":"Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M (2011) A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer\u2019s disease. J Neurochem 119(6):1330\u20131340. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07532.x","journal-title":"J Neurochem"},{"issue":"2","key":"637_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","volume":"288","author":"L Avrahami","year":"2013","unstructured":"Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar-Finkelman H (2013) Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. J Biol Chem 288(2):1295\u20131306. https:\/\/doi.org\/10.1074\/jbc.M112.409250","journal-title":"J Biol Chem"},{"issue":"1","key":"637_CR29","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1038\/ncomms7765","volume":"6","author":"R Ko","year":"2015","unstructured":"Ko R, Park JH, Ha H, Choi Y, Lee SY (2015) Glycogen synthase kinase 3\u03b2 ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production. Nat Commun 6(1):6765. https:\/\/doi.org\/10.1038\/ncomms7765","journal-title":"Nat Commun"},{"issue":"10","key":"637_CR30","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.4049\/jimmunol.181.10.6797","volume":"181","author":"H Wang","year":"2008","unstructured":"Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M (2008) IFN-\u03b2 production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-\u03b21. J Immunol 181(10):6797\u20136802. https:\/\/doi.org\/10.4049\/jimmunol.181.10.6797","journal-title":"J Immunol"},{"issue":"8","key":"637_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni1221","volume":"6","author":"M Martin","year":"2005","unstructured":"Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor\u2013mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6(8):777\u2013784. https:\/\/doi.org\/10.1038\/ni1221","journal-title":"Nat Immunol"},{"key":"637_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","volume":"65","author":"MA Hermida","year":"2017","unstructured":"Hermida MA, Dinesh Kumar J, Leslie NR (2017) GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network. Adv Biol Regulation 65:5\u201315. https:\/\/doi.org\/10.1016\/j.jbior.2017.06.003","journal-title":"Adv Biol Regulation"},{"key":"637_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112968","volume":"398","author":"X Tan","year":"2021","unstructured":"Tan X, Liang Z, Li Y, Zhi Y, Yi L, Bai S, Forest KH, Nichols RA, Dong Y, Li QX (2021) Isoorientin, a GSK-3\u03b2 inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP\/PS1 model mice. Behav Brain Res 398:112968. https:\/\/doi.org\/10.1016\/j.bbr.2020.112968","journal-title":"Behav Brain Res"},{"key":"637_CR34","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.rechem.2024.101500","volume":"7","author":"N Jitendra Joshi","year":"2024","unstructured":"Jitendra Joshi N (2024) Navigating the GSK-3\u03b2 inhibitors as versatile multi-target drug ligands in Alzheimer\u2019s disease intervention\u2014a comprehensive review. Result Chem 7:101500. https:\/\/doi.org\/10.1016\/j.rechem.2024.101500","journal-title":"Result Chem"},{"issue":"8","key":"637_CR35","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1142\/s0192415x16500853","volume":"44","author":"ZY Wang","year":"2016","unstructured":"Wang ZY, Liu JG, Li H, Yang HM (2016) Pharmacological effects of active components of chinese herbal medicine in the treatment of Alzheimer\u2019s disease: a review. Am J Chin Med 44(8):1525\u20131541. https:\/\/doi.org\/10.1142\/s0192415x16500853","journal-title":"Am J Chin Med"},{"issue":"1","key":"637_CR36","doi-asserted-by":"publisher","first-page":"18045","DOI":"10.1038\/s41598-019-54557-5","volume":"9","author":"G Griebel","year":"2019","unstructured":"Griebel G, Stemmelin J, Lopez-Grancha M, Boulay D, Boquet G, Slowinski F, Pichat P, Beesk\u00e9 S, Tanaka S, Mori A, Fujimura M, Eguchi J (2019) The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer\u2019s disease in rodents. Sci Rep 9(1):18045. https:\/\/doi.org\/10.1038\/s41598-019-54557-5","journal-title":"Sci Rep"},{"issue":"3","key":"637_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/jnc.12203","volume":"125","author":"B Georgievska","year":"2013","unstructured":"Georgievska B, Sandin J, Doherty J, M\u00f6rtberg A, Neelissen J, Andersson A, Gruber S, Nilsson Y, Sch\u00f6tt P, Arvidsson PI, Hellberg S, Osswald G, Berg S, F\u00e4lting J, Bhat RV (2013) AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. J Neurochem 125(3):446\u2013456. https:\/\/doi.org\/10.1111\/jnc.12203","journal-title":"J Neurochem"},{"issue":"17","key":"637_CR38","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2174\/0113895575263783231009051957","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Wang F, Jia X, Yao L, Liu Y (2024) Research mechanism and progress of the natural compound curcumin in treating Alzheimer\u00b4s disease. Mini Rev Med Chem 24(17):1590\u20131601. https:\/\/doi.org\/10.2174\/0113895575263783231009051957","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"637_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jgr.2023.03.001","volume":"47","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang Z, Liu J, Guo M, Li H (2023) Panax ginseng in the treatment of Alzheimer\u2019s disease and vascular dementia. J Ginseng Res 47(4):506\u2013514. https:\/\/doi.org\/10.1016\/j.jgr.2023.03.001","journal-title":"J Ginseng Res"},{"key":"637_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778847","volume":"12","author":"C Zhong","year":"2021","unstructured":"Zhong C, Lin Z, Ke L, Shi P, Li S, Huang L, Lin X, Yao H (2021) Recent research progress (2015\u20132021) and perspectives on the pharmacological effects and mechanisms of tanshinone IIA. Front Pharmacol 12:778847. https:\/\/doi.org\/10.3389\/fphar.2021.778847","journal-title":"Front Pharmacol"},{"issue":"8","key":"637_CR41","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1038\/s41380-024-02525-5","volume":"29","author":"ZSJ Liu","year":"2024","unstructured":"Liu ZSJ, Truong TTT, Bortolasci CC, Spolding B, Panizzutti B, Swinton C, Kim JH, Hern\u00e1ndez D, Kidnapillai S, Gray L, Berk M, Dean OM, Walder K (2024) The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model. Mol Psychiatry 29(8):2487\u20132495. https:\/\/doi.org\/10.1038\/s41380-024-02525-5","journal-title":"Mol Psychiatry"},{"issue":"5","key":"637_CR42","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s11064-022-03530-2","volume":"47","author":"M Shukla","year":"2022","unstructured":"Shukla M, Wongchitrat P, Govitrapong P (2022) A synopsis of multitarget potential therapeutic effects of huperzine a in diverse pathologies-emphasis on Alzheimer\u2019s disease pathogenesis. Neurochem Res 47(5):1166\u20131182. https:\/\/doi.org\/10.1007\/s11064-022-03530-2","journal-title":"Neurochem Res"},{"key":"637_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417233","author":"S Galati","year":"2023","unstructured":"Galati S, Di Stefano M, Bertini S, Granchi C, Giordano A, Gado F, Macchia M, Tuccinardi T, Poli G (2023) Identification of new gsk3\u03b2 inhibitors through a consensus machine learning-based virtual screening. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242417233","journal-title":"Int J Mol Sci"},{"issue":"1","key":"637_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4062\/biomolther.2022.035","volume":"31","author":"CH Lin","year":"2023","unstructured":"Lin CH, Hsieh YS, Sun YC, Huang WH, Chen SL, Weng ZK, Lin TH, Wu YR, Chang KH, Huang HJ, Lee GC, Hsieh-Li HM, Lee-Chen GJ (2023) Virtual screening and testing of GSK-3 inhibitors using human SH-SY5Y cells expressing tau folding reporter and mouse hippocampal primary culture under tau cytotoxicity. Biomol Ther 31(1):127\u2013138. https:\/\/doi.org\/10.4062\/biomolther.2022.035","journal-title":"Biomol Ther"},{"key":"637_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biochi.2024.05.002","volume":"225","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, Gupta A, Marzook H, Woodgett JR, Saleh MA, Qaisar R (2024) Natural compound screening predicts novel GSK-3 isoform-specific inhibitors. Biochimie 225:68\u201380. https:\/\/doi.org\/10.1016\/j.biochi.2024.05.002","journal-title":"Biochimie"},{"issue":"14","key":"637_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167994","volume":"435","author":"S Bittrich","year":"2023","unstructured":"Bittrich S, Bhikadiya C, Bi C, Chao H, Duarte JM, Dutta S, Fayazi M, Henry J, Khokhriakov I, Lowe R, Piehl DW, Segura J, Vallat B, Voigt M, Westbrook JD, Burley SK, Rose Y (2023) RCSB protein data bank: efficient searching and simultaneous access to one million computed structure models alongside the PDB structures enabled by architectural advances. J Mol Biol 435(14):167994. https:\/\/doi.org\/10.1016\/j.jmb.2023.167994","journal-title":"J Mol Biol"},{"issue":"D1","key":"637_CR47","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"T.U. Consortium","year":"2020","unstructured":"T.U. Consortium (2020) UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 49(D1):D480\u2013D489. https:\/\/doi.org\/10.1093\/nar\/gkaa1100","journal-title":"Nucleic Acids Res"},{"issue":"39","key":"637_CR48","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1039\/d3sc02139d","volume":"14","author":"Q Lv","year":"2023","unstructured":"Lv Q, Chen G, He H, Yang Z, Zhao L, Chen HY, Chen CY (2023) TCMBank: bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining. Chem Sci 14(39):10684\u201310701. https:\/\/doi.org\/10.1039\/d3sc02139d","journal-title":"Chem Sci"},{"issue":"D1","key":"637_CR49","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2021","unstructured":"Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J, Bu D, Liu X, Huo P, Cao W, Dong Q, Wu J, Zeng X, Wu Y, Zhao Y (2021) HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 49(D1):D1197-d1206. https:\/\/doi.org\/10.1093\/nar\/gkaa1063","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"637_CR50","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373-d1380. https:\/\/doi.org\/10.1093\/nar\/gkac956","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"637_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"W1","key":"637_CR52","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.1093\/nar\/gkv352","volume":"43","author":"M Davies","year":"2015","unstructured":"Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP (2015) ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 43(W1):W612\u2013W620. https:\/\/doi.org\/10.1093\/nar\/gkv352","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"637_CR53","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"issue":"15","key":"637_CR54","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39(15):2887\u20132893. https:\/\/doi.org\/10.1021\/jm9602928","journal-title":"J Med Chem"},{"issue":"4","key":"637_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina D (1999) Unsupervised data base clustering based on daylight\u2019s fingerprint and tanimoto similarity: a fast and automated way to cluster small and large data sets. J Chem Inf Comput Sci 39(4):747\u2013750. https:\/\/doi.org\/10.1021\/ci9803381","journal-title":"J Chem Inf Comput Sci"},{"issue":"16","key":"637_CR56","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1021\/acs.jmedchem.9b00855","volume":"63","author":"X Li","year":"2020","unstructured":"Li X, Li Z, Wu X, Xiong Z, Yang T, Fu Z, Liu X, Tan X, Zhong F, Wan X, Wang D, Ding X, Yang R, Hou H, Li C, Liu H, Chen K, Jiang H, Zheng M (2020) Deep learning enhancing kinome-wide polypharmacology profiling: model construction and experiment validation. J Med Chem 63(16):8723\u20138737. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00855","journal-title":"J Med Chem"},{"issue":"1","key":"637_CR57","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12967-023-04443-6","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Sun L, Xu Y, Liang P, Xu K, Huang J (2023) Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation. J Transl Med 21(1):579. https:\/\/doi.org\/10.1186\/s12967-023-04443-6","journal-title":"J Transl Med"},{"issue":"8","key":"637_CR58","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Modeling 61(8):3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Modeling"},{"issue":"1","key":"637_CR59","doi-asserted-by":"publisher","DOI":"10.1088\/1755-1315\/218\/1\/012143","volume":"218","author":"N Liu","year":"2019","unstructured":"Liu N, Xu Z (2019) Using LeDock as a docking tool for computational drug design. IOP Conf Series 218(1):012143. https:\/\/doi.org\/10.1088\/1755-1315\/218\/1\/012143","journal-title":"IOP Conf Series"},{"issue":"15","key":"637_CR60","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC (2015) DOCK 6: Impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156. https:\/\/doi.org\/10.1002\/jcc.23905","journal-title":"J Comput Chem"},{"issue":"7","key":"637_CR61","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1021\/acs.jcim.3c00253","volume":"64","author":"X Zhang","year":"2024","unstructured":"Zhang X, Gao H, Wang H, Chen Z, Zhang Z, Chen X, Li Y, Qi Y, Wang R (2024) PLANET: a multi-objective graph neural network model for protein-ligand binding affinity prediction. J Chem Inf Model 64(7):2205\u20132220. https:\/\/doi.org\/10.1021\/acs.jcim.3c00253","journal-title":"J Chem Inf Model"},{"issue":"9","key":"637_CR62","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s43588-023-00511-5","volume":"3","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang O, Shen C, Qu W, Chen S, Cao H, Kang Y, Wang Z, Wang E, Zhang J, Deng Y, Liu F, Wang T, Du H, Wang L, Pan P, Chen G, Hsieh C-Y, Hou T (2023) Efficient and accurate large library ligand docking with KarmaDock. Nat Comput Sci 3(9):789\u2013804. https:\/\/doi.org\/10.1038\/s43588-023-00511-5","journal-title":"Nat Comput Sci"},{"key":"637_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.858126","volume":"16","author":"R Kumar","year":"2022","unstructured":"Kumar R, Sharma A, Alexiou A, Bilgrami AL, Kamal MA, Ashraf GM (2022) DeePred-BBB: a blood brain barrier permeability prediction model with improved accuracy. Front Neurosci 16:858126. https:\/\/doi.org\/10.3389\/fnins.2022.858126","journal-title":"Front Neurosci"},{"issue":"9","key":"637_CR64","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"issue":"1","key":"637_CR65","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"1","key":"637_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, Wang N-N, Yao Z-J, Zhang L, Cheng Y, Ouyang D, Lu A-P, Cao D-S (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminf 10(1):29. https:\/\/doi.org\/10.1186\/s13321-018-0283-x","journal-title":"J Cheminf"},{"issue":"11","key":"637_CR67","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"F Cheng","year":"2012","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52(11):3099\u20133105. https:\/\/doi.org\/10.1021\/ci300367a","journal-title":"J Chem Inf Model"},{"issue":"9","key":"637_CR68","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511\u20131519. https:\/\/doi.org\/10.1002\/pro.5560020916","journal-title":"Protein Sci"},{"issue":"5016","key":"637_CR69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.1853201","volume":"253","author":"JU Bowie","year":"1991","unstructured":"Bowie JU, L\u00fcthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253(5016):164\u2013170. https:\/\/doi.org\/10.1126\/science.1853201","journal-title":"Science"},{"issue":"4","key":"637_CR70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/bf00228148","volume":"8","author":"RA Laskowski","year":"1996","unstructured":"Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477\u2013486. https:\/\/doi.org\/10.1007\/bf00228148","journal-title":"J Biomol NMR"},{"key":"637_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116065","volume":"265","author":"Z Cheng","year":"2024","unstructured":"Cheng Z, Han T, Yao J, Wang K, Dong X, Yu F, Huang H, Han M, Liao Q, He S, Lyu W, Li Q (2024) Targeting glycogen synthase kinase-3\u03b2 for Alzheimer\u2019s disease: recent advances and future prospects. Eur J Med Chem 265:116065. https:\/\/doi.org\/10.1016\/j.ejmech.2023.116065","journal-title":"Eur J Med Chem"},{"key":"637_CR72","doi-asserted-by":"publisher","first-page":"107324","DOI":"10.1016\/j.bioorg.2024.107324","volume":"146","author":"E Abdo Moustafa","year":"2024","unstructured":"Abdo Moustafa E, Abdelrasheed Allam H, Fouad MA, El Kerdawy AM (2024) Discovery of novel quinolin-2-one derivatives as potential GSK-3\u03b2 inhibitors for treatment of Alzheimer\u2019s disease: ph armacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation. Bioorg Chem 146:107324. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107324","journal-title":"Bioorg Chem"},{"issue":"17","key":"637_CR73","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1021\/acschemneuro.4c00365","volume":"15","author":"I G\u00f3ral","year":"2024","unstructured":"G\u00f3ral I, Wichur T, S\u0142ugocka E, Grygier P, G\u0142uch-Lutwin M, Mordyl B, Honkisz-Orzechowska E, Sza\u0142aj N, Gody\u0144 J, Panek D, Zar\u0119ba P, Sarka A, \u017bmudzki P, Latacz G, Pustelny K, Bucki A, Czarna A, Menezes F, Wi\u0119ckowska A (2024) Exploring novel GSK-3\u03b2 inhibitors for anti-neuroinflammatory and neuroprotective effects: synthesis, crystallography, computational analysis, and biological evaluation. ACS Chem Neurosci 15(17):3181\u20133201. https:\/\/doi.org\/10.1021\/acschemneuro.4c00365","journal-title":"ACS Chem Neurosci"},{"issue":"14","key":"637_CR74","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1080\/07391102.2023.2238062","volume":"42","author":"S Benghanem","year":"2024","unstructured":"Benghanem S, Mesli F, Fatima Zohra HA, Nacereddine C, Hadjer C, Abdellatif M (2024) Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3\u03b2) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis. J Biomol Struct Dyn 42(14):7091\u20137106. https:\/\/doi.org\/10.1080\/07391102.2023.2238062","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"637_CR75","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1021\/acsmedchemlett.9b00177","volume":"10","author":"F Heider","year":"2019","unstructured":"Heider F, Pantsar T, Kudolo M, Ansideri F, De Simone A, Pruccoli L, Schneider T, Goettert MI, Tarozzi A, Andrisano V, Laufer SA, Koch P (2019) Pyridinylimidazoles as GSK3\u03b2 inhibitors: the impact of tautomerism on compound activity via water networks. ACS Med Chem Lett 10(10):1407\u20131414. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00177","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"637_CR76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1866-1955-4-4","volume":"4","author":"GA Abu Shmais","year":"2012","unstructured":"Abu Shmais GA, Al-Ayadhi LY, Al-Dbass AM, El-Ansary AK (2012) Mechanism of nitrogen metabolism-related parameters and enzyme activities in the pathophysiology of autism. J Neurodev Disord 4(1):4. https:\/\/doi.org\/10.1186\/1866-1955-4-4","journal-title":"J Neurodev Disord"},{"issue":"2","key":"637_CR77","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jimd.12071","volume":"42","author":"A Oyarzabal","year":"2019","unstructured":"Oyarzabal A, Marin-Valencia I (2019) Synaptic energy metabolism and neuronal excitability, in sickness and health. J Inherit Metab Dis 42(2):220\u2013236. https:\/\/doi.org\/10.1002\/jimd.12071","journal-title":"J Inherit Metab Dis"},{"key":"637_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015251","author":"N Kolks","year":"2023","unstructured":"Kolks N, Neumaier F, Neumaier B, Zlatopolskiy BD (2023) Preparation of N(In)-methyl-6-[(18)F]fluoro- and 5-hydroxy-7-[(18)F]fluorotryptophans as candidate PET-tracers for pathway-specific visualization of tryptophan metabolism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242015251","journal-title":"Int J Mol Sci"},{"key":"637_CR79","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fpsyt.2020.00381","volume":"11","author":"X Shao","year":"2020","unstructured":"Shao X, Zhu G (2020) Associations among monoamine neurotransmitter pathways, personality traits, and major depressive disorder. Front Psych 11:381. https:\/\/doi.org\/10.3389\/fpsyt.2020.00381","journal-title":"Front Psych"},{"issue":"30","key":"637_CR80","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1021\/acs.jafc.4c02063","volume":"72","author":"Y Ni","year":"2024","unstructured":"Ni Y, Wang Z, Zhuge F, Zhou K, Zheng L, Hu X, Wang S, Fu O, Fu Z (2024) Hydrolyzed chicken meat extract and its bioactive cyclopeptides protect neural function by attenuating inflammation and apoptosis via PI3K\/AKT and AMPK pathways. J Agric Food Chem 72(30):16708\u201316725. https:\/\/doi.org\/10.1021\/acs.jafc.4c02063","journal-title":"J Agric Food Chem"},{"issue":"11","key":"637_CR81","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.1074\/jbc.M412017200","volume":"280","author":"PE Neagoe","year":"2005","unstructured":"Neagoe PE, Lemieux C, Sirois MG (2005) Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J Biol Chem 280(11):9904\u20139912. https:\/\/doi.org\/10.1074\/jbc.M412017200","journal-title":"J Biol Chem"},{"issue":"1","key":"637_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/pl00000158","volume":"46","author":"PF Mannaioni","year":"1997","unstructured":"Mannaioni PF, Di Bello MG, Masini E (1997) Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 46(1):4\u201318. https:\/\/doi.org\/10.1007\/pl00000158","journal-title":"Inflamm Res"},{"issue":"1","key":"637_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41598-023-50992-7","volume":"14","author":"V Pandya","year":"2024","unstructured":"Pandya V, Rao P, Prajapati J, Rawal RM, Goswami D (2024) Pinpointing top inhibitors for GSK3\u03b2 from pool of indirubin derivatives using rigorous computational workflow and their validation using molecular dynamics (MD) simulations. Sci Rep 14(1):49. https:\/\/doi.org\/10.1038\/s41598-023-50992-7","journal-title":"Sci Rep"},{"key":"637_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128375","volume":"52","author":"BS Choudhary","year":"2021","unstructured":"Choudhary BS, Sukanya P, Mehta S, Bach S, Ruchaud T, Robert B, Josselin S, Filipek RM (2021) Discovery of thiazolidin-4-one analogue as selective GSK-3\u03b2 inhibitor through structure based virtual screening. Bioorg Med Chem Lett 52:128375. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128375","journal-title":"Bioorg Med Chem Lett"},{"key":"637_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114095","volume":"229","author":"W Liu","year":"2022","unstructured":"Liu W, Liu X, Liu W, Gao Y, Wu L, Huang Y, Chen H, Li D, Zhou L, Wang N, Xu Z, Jiang X, Zhao Q (2022) Discovery of novel \u03b2-carboline derivatives as selective AChE inhibitors with GSK-3\u03b2 inhibitory property for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 229:114095. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114095","journal-title":"Eur J Med Chem"},{"key":"637_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106663","volume":"138","author":"N Yan","year":"2023","unstructured":"Yan N, Xie F, Tang L-Q, Wang D-F, Li X, Liu C, Liu Z-P (2023) Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3\u03b2 inhibitors for Alzheimer\u2019s disease. Bioorg Chem 138:106663. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106663","journal-title":"Bioorg Chem"},{"key":"637_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105655","volume":"107","author":"X Zhang","year":"2023","unstructured":"Zhang X, Guo Y, Zhang Z, Wu X, Li L, Yang Z, Li Z (2023) Neuroprotective effects of bavachin against neuroinflammation and oxidative stress-induced neuronal damage via activation of Sirt1\/Nrf2 pathway and inhibition of NF-\u03baB pathway. J Funct Foods 107:105655. https:\/\/doi.org\/10.1016\/j.jff.2023.105655","journal-title":"J Funct Foods"},{"key":"637_CR88","doi-asserted-by":"publisher","first-page":"7460781","DOI":"10.1155\/2020\/7460781","volume":"2020","author":"L Yang","year":"2020","unstructured":"Yang L, Hou A, Wang S, Zhang J, Man W, Guo X, Yang B, Jiang H, Kuang H, Wang Q (2020) A review of the botany, traditional use, phytochemistry, analytical methods, pharmacological effects, and toxicity of angelicae pubescentis radix. Evid-based Complement Alternat Med 2020:7460781. https:\/\/doi.org\/10.1155\/2020\/7460781","journal-title":"Evid-based Complement Alternat Med"},{"issue":"2","key":"637_CR89","doi-asserted-by":"publisher","first-page":"e202401653","DOI":"10.1002\/cbdv.202401653","volume":"22","author":"Y Wang","year":"2025","unstructured":"Wang Y, Sun F, Liang Y, Yan M, Hou Y, Hua H, Zhou D, Li N (2025) Study on the chemical components and anti-neuroinflammatory activity of the roots of clausena excavate Burm. f. Chem Biodiv 22(2):e202401653. https:\/\/doi.org\/10.1002\/cbdv.202401653","journal-title":"Chem Biodiv"},{"issue":"3","key":"637_CR90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejmech.2005.10.018","volume":"41","author":"N Zhang","year":"2006","unstructured":"Zhang N, Jiang Y, Zou J, Zhang B, Jin H, Wang Y, Yu Q (2006) 3D QSAR for GSK-3\u03b2 inhibition by indirubin analogues. Eur J Med Chem 41(3):373\u2013378. https:\/\/doi.org\/10.1016\/j.ejmech.2005.10.018","journal-title":"Eur J Med Chem"},{"issue":"12","key":"637_CR91","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00894-009-0498-x","volume":"15","author":"KH Kim","year":"2009","unstructured":"Kim KH, Gaisina I, Gallier F, Holzle D, Blond SY, Mesecar A, Kozikowski AP (2009) Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors. J Mol Model 15(12):1463\u20131479. https:\/\/doi.org\/10.1007\/s00894-009-0498-x","journal-title":"J Mol Model"},{"issue":"4","key":"637_CR92","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11030-011-9325-2","volume":"15","author":"I Garc\u00eda","year":"2011","unstructured":"Garc\u00eda I, Fall Y, Garc\u00eda-Mera X, Prado-Prado F (2011) Theoretical study of GSK-3\u03b1: neural networks QSAR studies for the design of new inhibitors using 2D descriptors. Mol Div 15(4):947\u2013955. https:\/\/doi.org\/10.1007\/s11030-011-9325-2","journal-title":"Mol Div"},{"key":"637_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-11026-0","author":"DG Niharika","year":"2024","unstructured":"Niharika DG, Salaria P, Reddy MA (2024) Integrated computational approaches for identification of potent pyrazole-based glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) inhibitors: 3D-QSAR virtual screening, docking, MM\/GBSA, EC, MD simulation studies. Mol Div. https:\/\/doi.org\/10.1007\/s11030-024-11026-0","journal-title":"Mol Div"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00637-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:57:00Z","timestamp":1762451820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00637-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00637-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}